Clinical & Pharma

Dengue Outbreak in Pinar del Río Spurs Health Actions
Clinical & Pharma Dengue Outbreak in Pinar del Río Spurs Health Actions

The situation in Pinar del Río, Cuba, has become increasingly precarious as health risks surge due to a dengue outbreak affecting municipalities such as Guane, Sandino, Los Palacios, Pinar del Río, and San Luis. Current circumstances have culminated in San Luis being officially designated as an

Is Gene Editing the Future of Cardiovascular Treatment?
Clinical & Pharma Is Gene Editing the Future of Cardiovascular Treatment?

In an era marked by rapid advancements in biotechnology, gene editing emerges as a promising frontier in the treatment of cardiovascular diseases. With the acquisition of Verve Therapeutics by Eli Lilly and Co., the pharmaceutical industry witnesses a strategic shift as major players venture deeper

Ashfield Partners with FRCOG to Enhance Health Services
Clinical & Pharma Ashfield Partners with FRCOG to Enhance Health Services

The small town of Ashfield has made a significant strategic move to enhance its public health services by transferring management responsibilities to the Franklin Regional Council of Governments (FRCOG). Following the resignation of Claudia Sarti, the town’s part-time Health Agent, Ashfield’s Board

Can Brain Resting States Unlock Secrets to Neuro Disorders?
Clinical & Pharma Can Brain Resting States Unlock Secrets to Neuro Disorders?

In the quest to unravel the complexities of the human brain, researchers often focus on activities associated with alert states, overlooking the intricate workings during rest. Recent groundbreaking studies are redefining this approach, revealing a treasure trove of information encoded in the

Can AI Accelerate Alzheimer's Clinical Trials?
Clinical & Pharma Can AI Accelerate Alzheimer's Clinical Trials?

The integration of artificial intelligence into Alzheimer's research has ignited significant interest as researchers seek innovative ways to enhance the efficiency and effectiveness of clinical trials. One study spearheaded by researchers at the University of Cambridge has gained attention,

How Will Derek Cummings Revolutionize Infectious Disease Research?
Clinical & Pharma How Will Derek Cummings Revolutionize Infectious Disease Research?

The world of infectious disease research has seen transformative changes, and Derek Cummings is at the forefront of these innovations. As he returns to Johns Hopkins University as the Bloomberg Distinguished Professor of Infectious Disease Dynamics, his imminent contribution promises to reshape the

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later